| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |